ArticleCancer chemotherapy and pharmacology2014

Trastuzumab, in combination with carboplatin and docetaxel, does not prolong the QT interval of patients with HER2-positive metastatic or locally advanced inoperable solid tumors: results from a phase Ib study.

Na Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.